# Front Cover

PMC · DOI: 10.1111/cns.14621 · CNS Neuroscience & Therapeutics · 2024-01-29

## TL;DR

This paper explores how a deficiency in SynCAM1 in certain brain cells contributes to cognitive issues in newborns exposed to sevoflurane.

## Contribution

It identifies SynCAM1's role in cognitive impairment linked to anesthetic exposure in neonates.

## Key findings

- SynCAM1 deficiency in parvalbumin interneurons is linked to cognitive impairment.
- Sevoflurane exposure exacerbates this issue in neonatal hippocampus.
- The study highlights a potential target for mitigating anesthetic-related cognitive effects.

## Abstract

The cover image is based on the Original Article SynCAM1 deficiency in the hippocampal parvalbumin interneurons contributes to sevoflurane‐induced cognitive impairment in neonatal by Ming‐ming Zhao et al., https://doi.org/10.1111/cns.14554.

## Linked entities

- **Genes:** CADM1 (cell adhesion molecule 1) [NCBI Gene 23705]
- **Chemicals:** sevoflurane (PubChem CID 5206)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10823880/full.md

---
Source: https://tomesphere.com/paper/PMC10823880